Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-003445
Filing Date
2020-01-13
Accepted
2020-01-13 16:02:43
Documents
1
Period of Report
2020-01-02

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3832
  Complete submission text file 0001104659-20-003445.txt   5123
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Issuer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address
Nazak Michael Adrian (Reporting) CIK: 0001799731 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38630 | Film No.: 20523864